Pinealon 20mg Australia | Nootropic Research Peptide
Pinealon is a synthetic tripeptide (Glu-Asp-Arg / EDR) from the Khavinson family of short peptide bioregulators, referenced in scientific literature examining gene expression and neuroprotective signalling pathways. As a nootropic research peptide available in Australia, it is cited across preclinical models investigating short-peptide bioregulator activity in neural cell systems.
Pinealon is supplied in a 20mg strength as a lyophilised powder with third-party verification.
What Is Pinealon?
Pinealon belongs to the short peptide bioregulator (cytogen) class of research peptides, developed at the St. Petersburg Institute of Bioregulation and Gerontology. In published literature it is referenced as a research tool for investigating neuroprotective signalling, oxidative-stress response and circadian-associated gene expression, and is a common subject in preclinical models exploring how short peptides interact with cellular regulatory pathways.
Pinealon Specifications
Peptide: Pinealon (EDR)
Sequence: Glu-Asp-Arg
CAS Number: 175175-23-2
Molecular Formula: C15H26N6O8
Molecular Weight: 418.4 g/mol
Strength: 20mg
Form: Lyophilised powder
Purity: 99%+
Verification: COA provided & independently tested
Storage: 2–8°C
Quality & Testing
Every batch supplied by Pureform Labs is independently analysed by a third-party laboratory for identity and purity. A Certificate of Analysis (COA) is available for each product so researchers can verify what they receive. View current lab results on our Lab Results page.
Ordering Pinealon in Australia
Pinealon is held in local Australian stock and dispatched same day on orders placed before cut-off, with tracked delivery nationwide. On arrival, store the powder at 2–8°C, away from light, to maintain stability.
Disclaimer: This product is intended strictly for laboratory research use only. It is not for human or animal consumption, and not for diagnostic or therapeutic use.
